Severe Refractory Systemic Lupus Erythematosus clinical trials

Explore recruiting severe refractory systemic lupus erythematosus clinical trials.

Recruiting severe refractory systemic lupus erythematosus studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Severe Refractory Systemic Lupus Erythematosus trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Single-Arm, Open-Label, Phase 1 Study to Determine the Safety, Tolerability and Preliminary Efficacy of Obecabtagene Autoleucel in Patients with Severe, Refractory Systemic Lupus Erythematosus

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

An open-label, multi-center, phase 1/2 study to assess safety, efficacy and cellular kinetics of YTB323 in participants with severe, refractory systemic lupus erythematosus (srSLE).

Spain, France, Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A SINGLE-ARM, OPEN-LABEL, PHASE II STUDY TO DETERMINE THE SAFETY AND EFFICACY OF OBECABTAGENE AUTOLEUCEL (OBE-CEL) IN PARTICIPANTS WITH SEVERE, REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS WITH ACTIVE LUPUS NEPHRITIS

Greece

Therapeutic exploratory (Phase II) EU CTIS Study details

Severe Refractory Systemic Lupus Erythematosus trials by city

Severe Refractory Systemic Lupus Erythematosus in Toronto Severe Refractory Systemic Lupus Erythematosus in Vancouver Severe Refractory Systemic Lupus Erythematosus in Montreal Severe Refractory Systemic Lupus Erythematosus in Calgary Severe Refractory Systemic Lupus Erythematosus in Edmonton Severe Refractory Systemic Lupus Erythematosus in Ottawa Severe Refractory Systemic Lupus Erythematosus in Winnipeg Severe Refractory Systemic Lupus Erythematosus in Quebec City Severe Refractory Systemic Lupus Erythematosus in Hamilton Severe Refractory Systemic Lupus Erythematosus in Kitchener Severe Refractory Systemic Lupus Erythematosus in London Severe Refractory Systemic Lupus Erythematosus in Halifax Severe Refractory Systemic Lupus Erythematosus in New York Severe Refractory Systemic Lupus Erythematosus in Los Angeles Severe Refractory Systemic Lupus Erythematosus in Chicago Severe Refractory Systemic Lupus Erythematosus in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease